Structure–Activity Assessment and In-Depth Analysis of Biased Agonism in a Set of Phenylalkylamine 5-HT2A Receptor Agonists

Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors

(2023) Maxemiliano V. Vargas et al.   SCIENCE

Community Guidelines for GPCR Ligand Bias: IUPHAR Review XX

(2022) Peter Kolb et al.   BRITISH JOURNAL OF PHARMACOLOGY

In vitro assays for the functional characterization of (psychedelic) substances at the serotonin receptor 5‐HT 2A R

(2022) Eline Pottie et al.   JOURNAL OF NEUROCHEMISTRY

Structure-based discovery of nonhallucinogenic psychedelic analogs

(2022) Dongmei Cao et al.   SCIENCE

The promises and perils of psychedelic pharmacology for psychiatry

(2022) Tristan D. McClure-Begley et al.   NATURE REVIEWS DRUG DISCOVERY

Effector membrane translocation biosensors reveal G protein and βarrestin coupling profiles of 100 therapeutically relevant GPCRs

(2022) Charlotte Avet et al.   eLife

Bespoke library docking for 5-HT2A receptor agonists with antidepressant activity

(2022) Anat Levit Kaplan et al.   NATURE

Pharmacological Mechanism of the Non-hallucinogenic 5-HT2A Agonist Ariadne and Analogs

(2022) Michael J. Cunningham et al.   ACS Chemical Neuroscience

Synthesis and Functional Characterization of 2-(2,5-Dimethoxyphenyl)-N-(2-fluorobenzyl)ethanamine (25H-NBF) Positional Isomers

(2021) Eline Pottie et al.   ACS Chemical Neuroscience

Structural insights into the lipid and ligand regulation of serotonin receptors

(2021) Peiyu Xu et al.   NATURE

OPLS4: Improving Force Field Accuracy on Challenging Regimes of Chemical Space

(2021) Chao Lu et al.   Journal of Chemical Theory and Computation

From Psychiatry to Neurology: Psychedelics as Prospective Therapeutics for Neurodegenerative Disorders

(2021) Urszula Kozlowska et al.   JOURNAL OF NEUROCHEMISTRY

Designer drugs: mechanism of action and adverse effects

(2020) Dino Luethi et al.   ARCHIVES OF TOXICOLOGY

In vitro structure–activity relationship determination of 30 psychedelic new psychoactive substances by means of β-arrestin 2 recruitment to the serotonin 2A receptor

(2020) Eline Pottie et al.   ARCHIVES OF TOXICOLOGY

Assessment of biased agonism at the A3 adenosine receptor using β-arrestin and miniGαi recruitment assays

(2020) Eline Pottie et al.   BIOCHEMICAL PHARMACOLOGY

The selective 5-HT2A receptor agonist 25CN-NBOH: Structure-activity relationship, in vivo pharmacology, and in vitro and ex vivo binding characteristics of [3H]25CN-NBOH

(2020) Anders A. Jensen et al.   BIOCHEMICAL PHARMACOLOGY

Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin Receptor

(2020) Kuglae Kim et al.   CELL

Identification of psychedelic new psychoactive substances (NPS) showing biased agonism at the 5-HT2AR through simultaneous use of β-arrestin 2 and miniGαq bioassays

(2020) Eline Pottie et al.   BIOCHEMICAL PHARMACOLOGY

International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function

(2020) Nicholas M. Barnes et al.   PHARMACOLOGICAL REVIEWS

Biased Receptor Signaling in Drug Discovery

(2019) Terry Kenakin   PHARMACOLOGICAL REVIEWS

Illuminating G-Protein-Coupling Selectivity of GPCRs

(2019) Asuka Inoue et al.   CELL

DARK Classics in Chemical Neuroscience: NBOMes

(2019) Christian B. M. Poulie et al.   ACS Chemical Neuroscience

Setup of a Serotonin 2A Receptor (5-HT2AR) Bioassay: Demonstration of Its Applicability To Functionally Characterize Hallucinogenic New Psychoactive Substances and an Explanation Why 5-HT2AR Bioassays Are Not Suited for Universal Activity-Based Screening of Biofluids for New Psychoactive Substances

(2019) Eline Pottie et al.   ANALYTICAL CHEMISTRY

Neurochemical pharmacology of psychoactive substituted N-benzylphenethylamines: high potency agonists at 5-HT2A receptors

(2018) Amy J Eshleman et al.   BIOCHEMICAL PHARMACOLOGY

Aminergic GPCR–Ligand Interactions: A Chemical and Structural Map of Receptor Mutation Data

(2018) Márton Vass et al.   JOURNAL OF MEDICINAL CHEMISTRY

Detailed Characterization of the In Vitro Pharmacological and Pharmacokinetic Properties of N -(2-Hydroxybenzyl)-2,5-Dimethoxy-4-Cyanophenylethylamine (25CN-NBOH), a Highly Selective and Brain-Penetrant 5-HT 2A Receptor Agonist

(2017) Anders A. Jensen et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

A kinetic view of GPCR allostery and biased agonism

(2017) J Robert Lane et al.   Nature Chemical Biology

Mini-G proteins: Novel tools for studying GPCRs in their active conformation

(2017) Rony Nehmé et al.   PLoS One

Systematic errors in detecting biased agonism: Analysis of current methods and development of a new model-free approach

(2017) H. Ongun Onaran et al.   Scientific Reports

5-HT2A/5-HT2C Receptor Pharmacology and Intrinsic Clearance of N-Benzylphenethylamines Modified at the Primary Site of Metabolism

(2016) Sebastian Leth-Petersen et al.   ACS Chemical Neuroscience

Practical guide for calculating and representing biased signaling by GPCR ligands: A stepwise approach

(2016) Karim Nagi et al.   METHODS

NanoLuc Complementation Reporter Optimized for Accurate Measurement of Protein Interactions in Cells

(2015) Andrew S. Dixon et al.   ACS Chemical Biology

Recent advances in the neuropsychopharmacology of serotonergic hallucinogens

(2015) Adam L. Halberstadt   BEHAVIOURAL BRAIN RESEARCH

Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs)

(2015) Anna Rickli et al.   NEUROPHARMACOLOGY

Generic GPCR residue numbers – aligning topology maps while minding the gaps

(2015) Vignir Isberg et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Synthesis and Structure–Activity Relationships of N-Benzyl Phenethylamines as 5-HT2A/2C Agonists

(2014) Martin Hansen et al.   ACS Chemical Neuroscience

Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes

(2014) Bruce E. Blough et al.   PSYCHOPHARMACOLOGY

Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments

(2013) G. Madhavi Sastry et al.   JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN

chemicalize.orgchemicalize.orgby ChemAxon Ltd.

(2012) Matthew Swain   Journal of Chemical Information and Modeling

Improved Treatment of Ligands and Coupling Effects in Empirical Calculation and Rationalization of pKaValues

(2011) Chresten R. Søndergaard et al.   Journal of Chemical Theory and Computation

PROPKA3: Consistent Treatment of Internal and Surface Residues in Empirical pKaPredictions

(2011) Mats H. M. Olsson et al.   Journal of Chemical Theory and Computation

Quantifying Ligand Bias at Seven-Transmembrane Receptors

(2011) S. Rajagopal et al.   MOLECULAR PHARMACOLOGY

Identification of Orthosteric and Allosteric Site Mutations in M2Muscarinic Acetylcholine Receptors That Contribute to Ligand-selective Signaling Bias

(2010) Karen J. Gregory et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Towards the comprehensive, rapid, and accurate prediction of the favorable tautomeric states of drug-like molecules in aqueous solution

(2010) Jeremy R. Greenwood et al.   JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN

The role of lipophilicity in determining binding affinity and functional activity for 5-HT2A receptor ligands

(2008) Matthew A. Parker et al.   BIOORGANIC & MEDICINAL CHEMISTRY

On the analysis of ligand-directed signaling at G protein-coupled receptors

(2008) Frederick J. Ehlert   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY